Question: Can you recommend a platform that uses liquid biopsy for early cancer detection and personalized treatment?

If you're looking for a more mature platform that uses liquid biopsy for early cancer detection and targeted treatment, Clinomics is a good option. Its precision medicine platform includes a liquid biopsy system, CD-Prime, that can identify cancer early and initiate treatment with a blood test. Clinomics also offers personal genome sequencing and analysis, precision medicine capabilities, and optimized big data solutions with AI technology for fast data analysis.

Another contender is Tempus, an AI-powered precision medicine platform that offers insights to help improve cancer care. It includes a liquid biopsy system, as well as other tools like a clinical assistant, care gap identifier and multimodal real-world data analysis. Tempus has received FDA Breakthrough Device Designation for its HLA-LOH Companion Diagnostic Test and offers an RNA sequencing test designed to help improve personalized patient care.

LifeOmic also offers a broad platform that combines genomic, clinical, imaging and population data to help doctors make decisions. Its platform includes the LifeOmic Oncology module, which uses machine learning and reference genome libraries for precision health, so it's a good option for those looking for a more general-purpose approach to cancer care.